Nate Jones

Wall Street Journal, ABC News and PBS NewsHour Win National Press Club Awards

Retrieved on: 
Tuesday, July 25, 2023
Online, General (United States), News, The Washington Post, Pentagon, Journalism, Hospice, International Consortium of Investigative Journalists, Insider, Throwaway, The New York Times, The Wall Street Journal, Reuters, White paper, NBC News, Nate Jones, National Press Club (United States), Southwest Airlines, The Philadelphia Inquirer, The New Yorker, Death, Press club, Multimedia, ProPublica, ABC News, Photography, New Yorker, CIA, Mount Washington Regional Airport, Texas Public Radio, News Hour, Supreme court, Twenty Four Seven (film), Joan, Clarence Thomas Supreme Court nomination, PBS, Publishing, Private investigator, Residential care

WASHINGTON, July 25, 2023 /PRNewswire/ -- National Press Club President Eileen O'Reilly today announced the winners of the prestigious National Press Club Journalism Awards.

Key Points: 
  • WASHINGTON, July 25, 2023 /PRNewswire/ -- National Press Club President Eileen O'Reilly today announced the winners of the prestigious National Press Club Journalism Awards.
  • The Wall Street Journal won in four categories in the National Press Club journalism contest.
  • "The National Press Club Journalism Awards celebrate the very best in journalism," said National Press Club President, Eileen O'Reilly.
  • Tickets to the awards dinner are $75 for the general public, $65 for members of the National Press Club and can be purchased online .

Xlear Provides New RCT Study on COVID-19 to the Dept. Of Justice in Ongoing Lawsuit; More Clinical Data Than FDA Relying on to Approve New Vaccines; Study Confirms Prior Studies on Effects of Nasal Hygiene on COVID-19

Retrieved on: 
Wednesday, August 31, 2022
Health, FDA, Infectious Diseases, Other Health, COVID-19, Clinical Trials, Pharmaceutical, Mortality, Patient, Treatment, CEO, National Council, Safety, International Forum of Allergy & Rhinology, Research, Coronavirus, Dominican Republic, Disease, Medical journal, Vaccine, Time, Nose, The BMJ, Federal Trade Commission, Study, Nate Jones, Interim, Smell, Prognosis, Aircraft pilot, Government, RCT, DEPT, Cureus, Anosmia, Justice, FDA, Xylitol, RNA transfection, Taste, FTC, Meta-analysis, Viral load, Dietary supplement, Pharmaceutical industry, Health, Bioethics, COVID-19

Most importantly, the new RCT pilot study found no anosmia (loss of sense of smell) among the outpatients who used Xlear.

Key Points: 
  • Most importantly, the new RCT pilot study found no anosmia (loss of sense of smell) among the outpatients who used Xlear.
  • Theyre relying on information that isnt even from these specific vaccines to approve them.
  • At the same time, Xlear has been used by millions of Americans for 20-plus years without a single adverse effect report.
  • The FDA is about to approve these vaccines for millions of Americans with no data.

With New Sponsorship, Xlear Inc. and NASCAR Driver Promote Healthy Lifestyle

Retrieved on: 
Wednesday, June 15, 2022
Other Health, Retail, Other Philanthropy, Other Entertainment, Men, Consumer, Philanthropy, Entertainment, LGBTQ+, Other Sports, Sports, Marketing, Advertising, Health, Communications, Other Travel, Specialty, Travel, CEO, Spry, NASCAR, Nate Jones, Devon, Pharmacy, Goal, Partnership

Xlear , Inc., the national leader in xylitol-based hygiene and wellness products, today announced its NASCAR Sponsorship of Devon Rouse.

Key Points: 
  • Xlear , Inc., the national leader in xylitol-based hygiene and wellness products, today announced its NASCAR Sponsorship of Devon Rouse.
  • This partnership is founded on likeminded goals of promoting a happy, healthy, and fulfilling lifestyle.
  • Xlear wants to support that success, states Nate Jones, CEO for Xlear.
  • Xlears partnership with Rouse, the first openly-gay NASCAR driver, serves to underscore Xlears commitment to diversity and inclusion.